Garantie de satisfaction à 100% Disponible immédiatement après paiement En ligne et en PDF Tu n'es attaché à rien
logo-home
ASPEN Self-Study CNSC Questions and Correct Answers the Latest Update and Recommended Version $15.49
Ajouter au panier

Examen

ASPEN Self-Study CNSC Questions and Correct Answers the Latest Update and Recommended Version

 0 fois vendu
  • Cours
  • ASPEN
  • Établissement
  • ASPEN

Modular products are used to enhance the nutrient profile of a feeding regimen. Which of the following combinations represents modular products? 1. Safflower oil, protein, glucose and selenium 2. Glucose, glutamine, water and MCT oil 3. Protein, cholecalciferol, fiber and safflower oil 4. MCT...

[Montrer plus]

Aperçu 4 sur 453  pages

  • 19 octobre 2024
  • 453
  • 2024/2025
  • Examen
  • Questions et réponses
  • ASPEN
  • ASPEN
avatar-seller
SmartExam
2 0 2 4 /2025 | © copyright | This work may not be copied for profit gain Excel!


ASPEN Self-Study CNSC Questions and
Correct Answers the Latest Update and
Recommended Version
Modular products are used to enhance the nutrient profile of a feeding regimen. Which of the

following combinations represents modular products?




1. Safflower oil, protein, glucose and selenium

2. Glucose, glutamine, water and MCT oil

3. Protein, cholecalciferol, fiber and safflower oil

4. MCT oil, glucose, fiber and protein


→ 4. MCT oil, glucose, fiber and protein


Protein powders, carbohydrate powders, fat emulsion, MCT oil, fiber and specific amino acids

are examples of what?

→ Modular products


Early initiation of enteral feeding has been suggested to benefit ICU patients by reducing

infectious complications, length of hospital stay and even possibly reducing mortality. Which

group of patients might be at significant risk from early enteral feeding?




1. Cancer patients who underwent surgery of the GIT

2. Patients with increasing vasopressor support

3. TBI patients with intracranial pressure controlled by hypertonic saline


1|Page| GradeA+ | 2 0 0 2 5

,2 0 2 4 /2025 | © copyright | This work may not be copied for profit gain Excel!

4. Patients admitted to the hospital with acute on chronic pancreatitis

→ 2. Patients with increasing vasopressor support


What is the risk of feeding a patient before hemodynamic stability has been achieved?

→ May increase the risk of intestinal ischemia as blood perfusion of the gut may be
compromised in a patient who is still requiring high doses of vasopressor drugs to
maintain blood pressure


When should EN be initiated in the hemodynamically unstable patient?

→ EN should be delayed until fluid resuscitation is complete


A patient with acute respiratory distress syndrome (ARDS) may benefit from a feeding

formula containing supplemental




1. arginine

2. glutamine

3. nucleic acids

4. omega-3 fatty acids

→ 4. omega-3 fatty acids


Define ARDS.

→ Acute respiratory distress syndrome - inflammatory response leading to diffuse
alveolar damage and lung capillary endothelial injury.


Why are formulas containing omega-3 fatty acids recommended in ALI and ARDS?



1|Page| GradeA+ | 2 0 0 2 5

,2 0 2 4 /2025 | © copyright | This work may not be copied for profit gain Excel!

→ Inflammatory mediators, including prostaglandins and leukotrienes derived from
arachidonic acid metabolism have been implicated in both ALI and ARDS. Formulas
containing omega-3 fatty acids may down regulate the inflammatory response through
the production of less inflammatory prostaglnadins and leukotrienes


What is the evidence for use of omega-3 fatty acids in ARDS and ALI?

→ Based on 3 level 1 studies the Guidelines for the Provision and Assessment of Nutrition
Support Therapy in the Adult Critically Ill Patient in 2009 recommended patients with
ARDS and severe ALI be placed on an enteral formulation characterized by an anti-
inflammatory lipid profile. Subsequent to the publication of those guidelines and
recommendations have been studies published in 2011 showing that enteral
supplementation of omega-3 fatty acids did not result in improved biomarkers of
inflammation or clinical outcomes


The use of enteral nutrition formulas enriched with BCAAs is best used for patients with:




1. cirrhosis

2. hepatic failure

3. liver transplantation

4. refractory encephalopathy

→ 4. refractory encephalopathy


What is the theory behind use of BCAAs in hepatic encephalopathy?

→ There is believed to be an increased ratio of aromatic amino acids to BCAAs in
patients experiencing hepatic encephalopathy. The decrease in BCAA is suspected to
be due to an increased breakdown in BCAA from skeletal muscles and utilization. The
increased levels of AAA generate false neurotransmitters, resulting in hepatic
encephalopathy symptoms.


What is the evidence for BCAA enriched amino acid enteral formulas?




1|Page| GradeA+ | 2 0 0 2 5

, 2 0 2 4 /2025 | © copyright | This work may not be copied for profit gain Excel!

→ Published randomized trials have shown mixed results in patients with hepatic failure
receiving these specialized formulas. Due to the lack of evidence supporting their use
and the increased cost of such products it has been suggested that the use of these
hepatic fomulas be limited to patients with encephalopathy refractory to standard
medical therapy (lactulose, non-absorbed antibiotics)


Enteral nutrition may be contraindicated in the early post-transplant period in adult patients

with hematopoietic cell transplants because of:




1. increased incidence of sinusitis with enteral feedings

2. lack of benefit from enteral feedings in allogeneic patients

3. gastrointestinal toxicities related to the conditioning regimen

4. improved survival seen in autologous patients receiving PN

→ 3. Gastrointestinal toxicities related to the conditioning regimen


Why is EN contraindicated in the early post-transplant period in adult patients with

hematopoietic cell transplants?


→ GI toxicities such as nausea, vomiting, delayed gastric emptying and diarrhea seen in
the first 2-3 weeks post-stem cell transplant may preclude EN. GI toxicity is most often
related to chemotherapy and total body irradiatin, however GI toxicity may also
result from other medications or early acute graft-versus-host disease in this patient
population.


Which nutrition therapy is preferred in early post-transplant hematopoietic cell transplant

patients (adult)?


→ Currently there is insufficient data to establish benefits of enteral nutrition over
parenteral nutrition with hematopoietic cell transplants. In one study, parenteral
nutrition was found to increase survival in allogeneic patients




1|Page| GradeA+ | 2 0 0 2 5

Les avantages d'acheter des résumés chez Stuvia:

Qualité garantie par les avis des clients

Qualité garantie par les avis des clients

Les clients de Stuvia ont évalués plus de 700 000 résumés. C'est comme ça que vous savez que vous achetez les meilleurs documents.

L’achat facile et rapide

L’achat facile et rapide

Vous pouvez payer rapidement avec iDeal, carte de crédit ou Stuvia-crédit pour les résumés. Il n'y a pas d'adhésion nécessaire.

Focus sur l’essentiel

Focus sur l’essentiel

Vos camarades écrivent eux-mêmes les notes d’étude, c’est pourquoi les documents sont toujours fiables et à jour. Cela garantit que vous arrivez rapidement au coeur du matériel.

Foire aux questions

Qu'est-ce que j'obtiens en achetant ce document ?

Vous obtenez un PDF, disponible immédiatement après votre achat. Le document acheté est accessible à tout moment, n'importe où et indéfiniment via votre profil.

Garantie de remboursement : comment ça marche ?

Notre garantie de satisfaction garantit que vous trouverez toujours un document d'étude qui vous convient. Vous remplissez un formulaire et notre équipe du service client s'occupe du reste.

Auprès de qui est-ce que j'achète ce résumé ?

Stuvia est une place de marché. Alors, vous n'achetez donc pas ce document chez nous, mais auprès du vendeur SmartExam. Stuvia facilite les paiements au vendeur.

Est-ce que j'aurai un abonnement?

Non, vous n'achetez ce résumé que pour $15.49. Vous n'êtes lié à rien après votre achat.

Peut-on faire confiance à Stuvia ?

4.6 étoiles sur Google & Trustpilot (+1000 avis)

63950 résumés ont été vendus ces 30 derniers jours

Fondée en 2010, la référence pour acheter des résumés depuis déjà 15 ans

Commencez à vendre!
$15.49
  • (0)
Ajouter au panier
Ajouté